Boundless Bio (Nasdaq: BOLD), a clinical-stage oncology company interrogating extrachromosomal DNA (ecDNA) biology to deliver ...
As the tax year draws to a close, tax-efficient investments once again move sharply into focus for advisers supporting ...
With investors rushing to secure Venture Capital Trust (VCT) allocations ahead of the expected reduction in the 30% income tax relief, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results